FibroBiologics, Inc. Common Stock (FBLG) vs Universe Pharmaceuticals Inc. (UPC)
A side-by-side comparison of FibroBiologics, Inc. Common Stock and Universe Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBLG
FibroBiologics, Inc. Common Stock
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UPC
Universe Pharmaceuticals Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FBLG vs UPC
growth of $100 · dividends reinvested · last 3yFBLG -99.8% (-87.3%/yr)UPC -99.6% (-84.8%/yr)UPC compounded faster over this window
FBLG UPC
FBLG vs UPC: by the numbers
- •UPC is the larger company ($3M vs $2M market cap).
- •Both run net losses; FBLG's is the smaller (0.00% vs -20.56% net margin).
Metrics side by side
Valuation
| Metric | FBLG | UPC |
|---|---|---|
| P/B ratio | 0.51 | 0.05 |
Profitability
| Metric | FBLG | UPC |
|---|---|---|
| Gross margin | 0.00% | 35.28% |
| Operating margin | 0.00% | -16.33% |
| Net margin | 0.00% | -20.56% |
| ROE | -391.26% | -6.54% |
| ROIC | -286.46% | -4.46% |
Growth (annualized)
| Metric | FBLG | UPC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.27% |
| Total return CAGR (5Y) | N/A | -78.19% |
Go deeper
Dig into the metrics
FibroBiologics, Inc. Common Stock ROEUniverse Pharmaceuticals ROEFibroBiologics, Inc. Common Stock operating marginUniverse Pharmaceuticals operating marginFibroBiologics, Inc. Common Stock revenue growthUniverse Pharmaceuticals revenue growthFibroBiologics, Inc. Common Stock free cash flowUniverse Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.